Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.

Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. J Clin Oncol. 2007 Sep 01; 25(25):3978-84.

View in: PubMed

subject areas

Adaptor Proteins, Signal Transducing
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Carcinoma, Adenoid Cystic
Disease-Free Survival
Epidermal Growth Factor
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasm Recurrence, Local
Protein-Tyrosine Kinases
Quinazolines
Salivary Gland Neoplasms
Treatment Outcome

authors with profiles

Everett E. Vokes